Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hind Lal

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Cell Physiology|September 30, 2024
Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intoleranceManisha Gupte, Prachi Umbarkar, Jacob Lemon, et al.
Journal of Cardiac Failure|September 6, 2017
Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing EnzymesManisha Gupte, Hind Lal, Firdos Ahmad, et al.
Circulation Research|March 14, 2024
Circadian Rhythms in Cardiovascular MetabolismHind Lal, Suresh Kumar Verma, Yajing Wang, et al.
Pharmacological Research|May 9, 2021
Repurposing Nintedanib for pathological cardiac remodeling and dysfunctionPrachi Umbarkar, Anand P Singh, Sultan Tousif, et al.
Cardiovascular Research|October 16, 2018
Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regenerationAnand Prakash Singh, Prachi Umbarkar, Yuanjun Guo, et al.
Cells|May 6, 2020
Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established ObesityManisha Gupte, Prachi Umbarkar, Anand Prakash Singh, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 24, 2023
GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefitPrachi Umbarkar, Sulivette Y Ruiz Ramirez, Angelica Toro Cora, et al.
Cells|February 15, 2022
Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose IntoleranceManisha Gupte, Sultan Tousif, Jacob J Lemon, et al.
Experimental Cell Research|October 18, 2011
A novel cardioprotective p38-MAPK/mTOR pathwayGonzalo Hernández, Hind Lal, Miguel Fidalgo, et al.
Journal of Molecular and Cellular Cardiology|July 31, 2017
Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosisYuanjun Guo, Manisha Gupte, Prachi Umbarkar, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Cell Physiology|September 30, 2024
Animal models of haploinsufficiency revealed the isoform-specific role of GSK-3 in HFD-induced obesity and glucose intoleranceManisha Gupte, Prachi Umbarkar, Jacob Lemon, et al.
Journal of Cardiac Failure|September 6, 2017
Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing EnzymesManisha Gupte, Hind Lal, Firdos Ahmad, et al.
Circulation Research|March 14, 2024
Circadian Rhythms in Cardiovascular MetabolismHind Lal, Suresh Kumar Verma, Yajing Wang, et al.
Pharmacological Research|May 9, 2021
Repurposing Nintedanib for pathological cardiac remodeling and dysfunctionPrachi Umbarkar, Anand P Singh, Sultan Tousif, et al.
Cardiovascular Research|October 16, 2018
Inhibition of GSK-3 to induce cardiomyocyte proliferation: a recipe for in situ cardiac regenerationAnand Prakash Singh, Prachi Umbarkar, Yuanjun Guo, et al.
Cells|May 6, 2020
Deletion of Cardiomyocyte Glycogen Synthase Kinase-3 Beta (GSK-3β) Improves Systemic Glucose Tolerance with Maintained Heart Function in Established ObesityManisha Gupte, Prachi Umbarkar, Anand Prakash Singh, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|April 24, 2023
GSK-3 at the heart of cardiometabolic diseases: Isoform-specific targeting is critical to therapeutic benefitPrachi Umbarkar, Sulivette Y Ruiz Ramirez, Angelica Toro Cora, et al.
Cells|February 15, 2022
Isoform-Specific Role of GSK-3 in High Fat Diet Induced Obesity and Glucose IntoleranceManisha Gupte, Sultan Tousif, Jacob J Lemon, et al.
Experimental Cell Research|October 18, 2011
A novel cardioprotective p38-MAPK/mTOR pathwayGonzalo Hernández, Hind Lal, Miguel Fidalgo, et al.
Journal of Molecular and Cellular Cardiology|July 31, 2017
Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosisYuanjun Guo, Manisha Gupte, Prachi Umbarkar, et al.
Pageof 7